Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
James Thomson
Morgridge Institute for Research, Inc., Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Opsis Therapeutics
Payment for services (e.g., consulting fees, honoraria, paid authorship)
This outside activity has a nexus with the investigator’s research activities because the outside activity arises from, relies upon, or is related to the expertise that qualifies this individual to participate in this federally funded research. The disclosed significant financial interest is related to the area of expertise of the investigator. The entity, Opsis Therapeutics, fabricates retinal cell grafts from induced-pluripotent stem cells and bio-compatible materials for delivery via standard surgical techniques.
The Institute has reasonably determined that the significant financial interest and its nexus with the investigator’s research could directly and significantly affect the design, conduct, or reporting of federally funded research, corresponding to the definition of a Financial Conflict of Interest thereby requiring management of the conflict.
Transplantation of MHC Homozygous Vascular Progenitors in Primates
Project Narrative, ?Transplantation of MHC homozygous vascular progenitors in primates.? Vascular transplants are used routinely to treat heart disease and peripheral vascular disease, but there is often no suitable vessel available for transplantation. Here we will study how to produce vascular progenitors from induced pluripotent stem (iPS) cells, assemble them into tissue engineered arteries, and test them in a genetically defined primate that should accurately model both the human circulatory and immune systems. The proposed studies will result in the production of cGMP human vascular progenitors to support the animal efficacy and safety studies required prior to the initiation of a clinical trial for critical limb ischemia.
Filed on April 06, 2018.
Tell us what you know about James Thomson's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
James Thomson filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| James Thomson | Morgridge Institute for Research, Inc. | Conflict of Interest | Cellular Dynamics International | >$600,000 |
| James Thomson | Morgridge Institute for Research, Inc. | Conflict of Interest | Cellular Dynamics International | >$600,000 |
| James Thomson | Morgridge Institute for Research, Inc. | Conflict of Interest | Cellular Dynamics International | $150,000 - $199,999 |
| James Thomson | Morgridge Institute for Research, Inc. | Conflict of Interest | Cellular Dynamics International | $150,000 - $199,999 |
| James Thomson | Morgridge Institute for Research, Inc. | Conflict of Interest | Opsis Therapeutics | $150,000 - $199,999 |
| James Thomson | Morgridge Institute for Research, Inc. | Conflict of Interest | Cellular Dynamics International | $0 - $4,999 |
| James Thomson | Morgridge Institute for Research, Inc. | Conflict of Interest | Cellular Dynamics International | $0 - $4,999 |
| James Thomson | Morgridge Institute for Research, Inc. | Conflict of Interest | Cellular Dynamics International | Value cannot be readily determined |
| James Thomson | Morgridge Institute for Research, Inc. | Conflict of Interest | Cellular Dynamics International | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.